Chemtrail what you need to know !....click to hear the audio.
Herbal therapists face regulation crackdown
The
government has announced plans to force all providers of unlicensed herbal
medicines to register with a regulator. It comes after several public
consultations on how best to police the industry. The Complementary and
Natural Healthcare Council (CNHC), will ensure practitioners are properly
trained and operating a safe business. But some have said the proposals do
not go far enough. From 2011 EU legislation will permit only statutorily
registered professionals to prescribe manufactured herbal remedies. It is
estimated that Britons spend about £1.6 billion a year on alternative
remedies. The CNHC was launched in 2009. Its main purpose was to hold a
voluntary register of complementary therapists such as massage therapists,
nutritional therapists and reflexologists.
Those providing unlicensed herbal medicines -
thought to be around 8,000 practitioners - are not currently covered by the
council. In future, to be accepted on the register those providing
unlicensed herbal medicines will have to show they have the right training and
experience, abide by a code of conduct and ensure they have insurance in place.
Clinics are not judged on whether the therapies they provide are
effective. Health Secretary Andy Burnham said: "Emerging evidence
clearly demonstrates that the public needs better protection, but in a way that
is measured and does not place unreasonable extra burdens on
practitioners." He added that he was in discussion with health
ministers in Scotland, Wales and Northern Ireland to come to a joint agreement
on legislation for regulation. Proposals for those providing acupuncture
are still being considered, he said, Maggie Dunn, head of the CNHC estimated
the proposals would mean many thousands of practitioners being forced to sign
up and meet their standards.
Flu jab could be replaced by skin patch
As the
pandemic virus has rapidly become the dominant influenza strain worldwide, it
can be assumed that most cases of influenza in The conventional flu jab could be replaced by a skin patch applied
by patients which would deliver the vaccine through hundreds of microscopic
needles that penetrate the outer layer of the skin before dissolving. The
scientists behind the development of the patch believe it could significantly
increase influenza vaccination in developing countries, as it can be
administered by someone with no medical training, according to a study
published in the journal Nature Medicine. The patch is placed on the skin and
left for 5-15 minutes, meaning the cost of mass vaccination could be vastly
reduced via self-medication. The patches would also eliminate dangers posed by
dirty needles, particularly in countries where conditions such as HIV and
hepatitis are endemic. Scientists in the US designed a 100-needle patch that
was first tested for its ability to penetrate pig skin, which is about the same
thickness as human skin. The microscopic needles are made of biodegradable
plastic that painlessly inoculate patients then dissolve harmlessly without
trace.
The patch
could greatly enhance flu vaccination programmes in the developing world, where
re-use of hypodermic needles leads to the spread of infections such as HIV and
hepatitis B, the study proposed. The patches do not need to be stored in
refrigerators and would remove the risk of resource-strapped health services re-using
dirty needles, as well as the problem of their safe disposal. "We envision
people getting the patch in the mail or at a pharmacy and then
self-administering it at home," said Dr Sean Sullivan, from the Georgia
Institute of Technology in Atlanta, which carried out the study. "Because
the microneedles on the patch dissolve away into the skin, there would be no
dangerous sharp needles left over." Flu vaccination is recommended every
winter for older people and those vulnerable to complications from an influenza
infection, costing the NHS a considerable amount of money. Although the study
focused on flu, the scientists believe the technique could also be extended for
use with other vaccines.
Professor
Mark Prausnitz, who led the study, said: "The dissolving microneedle patch
could open up many new doors for immunisation programmes by eliminating the
need for trained personnel to carry out the vaccination. This approach could
make a significant impact because it could enable self-administration as well as
simplify vaccination programmes in schools and assisted living
facilities." Tests on mice found those vaccinated with the microneedles
fought off influenza infections better than those rodents that received
traditional hypodermic needle jabs. Prof Prausnitz, said: "We have shown
that a dissolving microneedle patch can vaccinate against influenza at least as
well, and probably better than, a traditional hypodermic needle."
Health Alert
